Metall Zug AG (METN) Fair Value & Analysis
Healthcare · CH · Market cap CHF 313M
Fair value as of: Jun 24, 2026
From 4 valuation models · updated 6 days ago
Share price +4.0% over the past month.
Price vs Fair Value (12 months)
12‑month range CHF 691.26 – CHF 1,041 · fair‑value band CHF 5,153 – CHF 8,588 · the CHF 722.00 price screens below the CHF 6,870 fair value. As of Jun 24, 2026.
✦ Find undervalued quality stocks — 35,000+ analysed Find stocks →Analysis
Metall Zug AG (METN) currently trades at CHF 722.00, while our model-based Fair Value estimate is CHF 6,870 — implying the stock looks roughly 851.5% undervalued today. We read business quality at 81/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Over the trailing twelve months, Metall Zug AG generated revenue of CHF 195M at a net margin of -7.8%. Revenue declined 1.8% year over year. It earns a return on equity of -3.6%. Net debt stands at CHF 137M. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Metall Zug AG, through its subsidiaries, engages in the medical devices, infection control, technology cluster and infrastructure, and other businesses in Switzerland, Europe, North America, South America, the Asia Pacific, and internationally. The company develops, manufactures, and distributes devices and solutions for medical diagnosis, microsurgery, and eye training. It also offers diagnostics equipment, such as slit lamps, tonometry devices, and perimetry and biometry equipment for cataract diagnosis and treatment; equipment for ophthalmologists, including tables, chairs, and industrial high-precision surgical microscopes; accessories, including measuring instruments for precision optics, lenses, software solutions, and comprehensive services; and augmented and virtual reality technology and digital imaging for the training and further education of eye care specialists. In addition, the company supplies dishwashers, thermal appliances, and cleaning agents for catering and hotel…
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Metall Zug AG reported revenue of CHF 195M in FY2025 versus CHF 662M in FY2021, a compound −26.4%/yr. Reported net income was −CHF 15.2M in FY2025.
Open the full interactive analysis →
Similar stocks
6 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABTT34 | R$37.76 | R$6.34 | -83% |
| Stryker Corporation S1YK34 | R$77.83 | R$8.47 | -89% |
| Medtronic plc MDT | $79.27 | $73.33 | -7% |
| Boston Scientific Corporation B1SX34 | R$247.01 | R$234.82 | -5% |
| Edwards Lifesciences Corporation EW | $87.45 | $41.02 | -53% |
| Siemens Healthineers AG SEMHF | $39.95 | $44.36 | +11% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Metall Zug AG (METN) undervalued?
What is the fair value of METN?
What is the quality score of METN?
What is the revenue of Metall Zug AG (METN)?
What is the net profit margin of METN?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.